// App-Quantinova.ai

TPS10588 : Safety and feasibility of magnetic resonance-guided high intensity focused ultrasound (MR-HIFU) for the ablation of relapsed or refractory pediatric solid tumors.

Researchers

Presenter

  • AeRang Kim

Principal Investigators

  • Karun Sharma

  • Pavel Yarmolenko

  • Haydar Celik

  • Rosandra Kaplan

  • Jeffrey S. Dome

  • Amanda Mahoney

  • Ari Partanen

  • Lizette Warner

  • Peter C W Kim

Medical Centers

  • The Center for Cancer and Blood Disorders, Washington, DC

  • Children's Natl Medcl Ctr, Washington, DC

  • National Cancer Institute, Pediatric Oncology Branch, Bethesda, MD

  • Philips North America, Andover, MA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • NCT02076906

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved